|
|
| March 30, 2009: Dr. Mark Turco and Dr. C. Michael Gibson discuss comparative effectiveness research |
Dr. Mark Turco and Dr. C. Michael Gibson discuss comparative effectiveness research at ACC
09 in Orlando, FL.
Disclosures for Dr. Gibson at the time of filming:
Present Research/Grant Funding
Schering Plough Corporation; Sanofi-Aventis; Baxter; FoldRx;
Genentech, Inc.; Astra Zeneca; HeartScape Technologies; Fold Rx;
Abbott; Cardica, Inc.; Johnson & Johnson Corporation; FibroGen, Inc.
Speakers Bureau
Schering Plough Corporation; Eli Lilly and Company; Daiichi Sankyo Company, Inc;
Consultant
The Medicines Company; Bayer Corporation; Archemix Corporation;
Heartscape Technologies, Inc.; Angel Medical Systems; Schering Plough
Corporation; Portola Corporation; John & Johnson Corporation; ICON
Medical Imaging; Jim Moran Heart and Vascular Research Institute
Stock Ownership
My wife owns stock in HealthMarx Inc.
Royalties as a Contributor
UpToDate in Cardiovascular Medicine
Past Research/Grant Funding/Past Speakers Bureau/Past Consulting
ActivBiotics, Inc.; Acusphere, Inc.; Astra; Sanofi-Aventis
Corporation; Bard Corporation; Boston Scientific Corporation; Bristol
Meyers Squibb Company; British Biotech, plc.; Ciba Geigy Corporation;
Corgentech, Inc.; COR Therapeutics; DVI Guidant Corporation;
GlaxoSmithKline; Genentech, Inc.; Merck & Co., Inc.; Millennium
Pharmaceuticals; NIH; Pfizer; Percusurge, Inc.; Smith Kline Beecham;
Sonus; St. Jude Medical; timi3 Systems, Inc.; Ascenta Therapeutics,
Inc; CardioKinetix, Inc.; Eli Lilly and Company; KAI Pharmaceuticals;
Nuvelo; INO Therapeutics, LLC; Point Biomedical Corporation; Portola
Pharmaceuticals, Inc.; The Medicines Company; Ascenta Therapeutics;
Atrium Medical Corporation; Biogen IDEC; PDL Pharmaceuticals; timi3
Systems; Momenta Pharmaceuticals; Novartis Corporation;
Current disclosures for Dr. Gibson can be found at:
http://en.wikidoc.org/index.php/C._Michael_Gibson
[ Download video ] |
|
No comments have been submitted
|